Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/PK5 stock hub

FRA/PK5 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/PK5is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

732M

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/PK5FRA/PK5

—

Loading chart…

In the news

Latest news · FRA/PK5

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.1

P25 n/aP50 n/aP75 n/a

Trailing P/E16.9

P25 n/aP50 n/aP75 n/a

ROE38.5

P25 n/aP50 n/aP75 n/a

ROIC79.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/PK5 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

185

Groups with data

Currency

CHF

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	DE
Employees	189
Employees Change	25%
Employees Change Percent	15.24
Enterprise value	EUR 654.9M
Exchange	Frankfurt Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 732M
Price	EUR 58.9
Price currency	EUR
Rev Per Employee	1,320,619.75x
Sic	2836
Symbol	fra/PK5
Website	https://www.basilea.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.9%
EV Earnings	15.15x
EV/EBIT	11.47x
EV/EBITDA	10.65x
EV/FCF	10.25x
EV/Sales	2.58x
FCF yield	8.73%
Forward P/E	12.08x
P/B ratio	5.33x
P/E ratio	16.94x
P/S ratio	2.93x
PE Ratio10 Y	63.74x
PE Ratio3 Y	10.55x
PE Ratio5 Y	23.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	22.48%
EBITDA Margin	23.26%
FCF margin	25.59%
Gross margin	37.51%
Gross Profit	EUR 93.6M
Gross Profit Growth	-20.46%
Gross Profit Growth Q	-32.9%
Gross Profit Growth3 Y	53.45%
Gross Profit Growth5 Y	-2.16%
Net Income	EUR 43.2M
Net Income Growth	-48.14%
Net Income Growth Q	-57.02%
Net Income Growth5 Y	-6.46%
Pretax Margin	19.74%
Profit Margin	17.32%
Profit Per Employee	EUR 228,685
ROA	12.1
Roa5y	8.66
ROCE	22.45
ROE	38.52
ROIC	79.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	-46.05
EPS Growth Q	-55.15
EPS Growth5 Y	-6.79
FCF Growth	-18.15%
FCF Growth Q	-33.45%
FCF Growth3 Y	85.38%
FCF Growth5 Y	17.16%
OCF Growth	-16.5%
OCF Growth Q	-30.84%
OCF Growth3 Y	81.99%
OCF Growth5 Y	16.63%
Revenue Growth	11.43x
Revenue Growth Q	-2.9x
Revenue Growth3 Y	15.96x
Revenue Growth5 Y	5.83x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.86
Assets	EUR 302.9M
Cash	EUR 171.6M
Current Assets	EUR 274.7M
Current Liabilities	EUR 53.7M
Debt	EUR 95.8M
Debt EBITDA	EUR 1.59
Debt Equity	EUR 0.7
Debt FCF	EUR 1.5
Equity	EUR 137.4M
Interest Coverage	15.56
Liabilities	EUR 165.5M
Long Term Assets	EUR 28.2M
Long Term Liabilities	EUR 111.8M
Net Cash	EUR 75.8M
Net Cash By Market Cap	EUR 10.36
Net Cash Growth	680.74%
Net Debt EBITDA	EUR -1.31
Net Debt Equity	EUR -0.55
Net Debt FCF	EUR -1.19
Tangible Book Value	EUR 137M
Tangible Book Value Per Share	EUR 11.15

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.11
Inventory Turnover	5.46
Net Working Capital	EUR 48.1M
Quick ratio	4.53
Working Capital	EUR 217.5M
Working Capital Turnover	EUR 1.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.23%
Dividend per share	EUR 0
Last Dividend	EUR 4.1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	58.26
All Time High	63.7
All Time High Change	-7.54%
All Time High Date	2026-02-11
All Time Low	48.15
All Time Low Change	22.33%
All Time Low Date	2025-11-10
ATR	1.02
Ch YTD	0.68
High	58.9
High52	63.7
High52 Date	2026-02-11
High52ch	-7.54%
Low	58.9
Low52	48.15
Low52 Date	2025-11-10
Low52ch	22.33%
Ma50ch	1.09%
RSI	50.66
RSI Monthly	0
RSI Weekly	62.05
Sharpe ratio	1.25x
Sortino ratio	2.23
Total Return	1.23%
Tr YTD	0.68
Tr1m	-0.51%
Tr1w	-1.67%
Tr3m	-3.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 56.1M
Operating Income Growth	-31.76
Operating Income Growth Q	-46.6
Operating Income Growth5 Y	-5.1
Operating margin	22.48

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,207,789%
Shares Insiders	0.68%
Shares Institutions	34.46%
Shares Qo Q	-2.36%
Shares Yo Y	-1.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 58.3M
Average Volume	18.15x
Bv Per Share	11.18
CAPEX	EUR -2.8M
Ch1m	-0.51
Ch1w	-1.67
Ch3m	-3.76
Change	-0.17%
Change From Open	0
Close	59
Days Gap	-0.17
Depreciation Amortization	1,979,784
Earnings Date	2026-08-18
EBIT	EUR 56.1M
EBITDA	EUR 58.1M
EPS	EUR 3.37
F Score	5
FCF	EUR 63.9M
FCF EV Yield	9.75x
Financing CF	-23,012,387
Fiscal Year End	December
Founded	2,000
Graham Number	29.41573
Graham Upside	-50.06
Income Tax	EUR 6.1M
Investing CF	-3,074,047
Is Primary Listing	0
Last Report Date	2025-12-31
Lynch Fair Value	EUR 17.39
Lynch Upside	-70.48
Ma20	59.08
Ma20ch	-0.3%
Net CF	40,575,914
Next Earnings Date	2026-08-18
Open	58.9
P FCF Ratio	11.46
P OCF Ratio	10.98
Ppne	19,808,753.8
Price Date	2026-05-08
Price EBITDA	EUR 12.61
Ptbv Ratio	5.34
Relative Volume	11.18x
Revenue	249,597,132x
SBC By Revenue	2.25x
Share Based Comp	5,626,086
Tax By Revenue	2.42x
Tax Rate	12.28%
Z Score	0.15

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/PK5 pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns FRA/PK5?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.5%

Share of float held by funds and institutions

Insider ownership

+0.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.2%

Negative means the company is buying back shares.

Technical

FRA/PK5 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

50.7

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/PK5

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/PK5 stock rating?

fra/PK5 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/PK5 analysis?

The full report lives at /stocks/fra/PK5/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/PK5?

The latest report frames fra/PK5 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/PK5 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.